中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1

文献类型:期刊论文

作者Wan, Hui-Xin; Zhou, Caihong; Zhang, Yueyun; Sun, Meiling; Wang, Xin; Yu, Hong; Yang, Xiaoke; Ye, Richard D.; Shen, Jing Kang; Wang, Ming-Wei
刊名BIOCHEMICAL PHARMACOLOGY
出版日期2007-07-15
卷号74期号:2页码:317-326
关键词formyl peptide receptor-like 1 chemotactic peptides Trp-Lys-Tyr-Met-Val-[D]Met structure-activity relationship peptidomimetic
ISSN号0006-2952
DOI10.1016/j.bcp.2007.04.016
文献子类Article
英文摘要Forrnyl peptide receptor-like 1 (FPRL1) is a structural homologue of FPR, which binds chemotactic peptides as small as three amino acids (e.g., fMet-Leu-Phe, fMLF) and activates potent bactericidal functions in neutrophils. In comparison, FPRL1 ligands include peptides of 6-104 amino acids, such as Trp-Lys-Tyr-Met-Val-[D]Met (WKYMVm) and other synthetic peptides. To determine the core peptide sequence required for FPRL1 activation, we prepared various analogues based on WKYMVm and evaluated their bioactivities in an FPRL1 -trans fected cell line. Although substitution of D-Met(6) resulted in loss of activity, removal of Val(5) together with D-Met(6) produced a peptide that retained most of the bioactivities of the parent peptide. The resulting peptide, WKYM, represents a core structure for an FPRL1 ligand. Further substitution of Lys' with Nle slightly improved the potency of the tetrapeptide, which selectively activates FPRL1 over FPR. Based on these structure-activity relationship studies, we propose a model in which the modified tetrapeptide Trp -Nle-Tyr- Met (WNleYM) binds to FPRL1 through aromatic interactions involving the side chains of Trp(1) and Tyr(3), hydrophobic interaction of Nle(2), and the thio-based hydrogen bonding of Met(4), with the respective residues in FPRL1 which have not been identified. The identification of the core sequence of a potent peptide agonist provides a structural basis for future design of peptidomimetics as potential therapeutic agents for FPRL1-related disorders. (C) 2007 Elsevier Inc. All rights reserved.
WOS关键词PROTEIN-COUPLED RECEPTORS ; VAL-D-MET ; CHEMOATTRACTANT RECEPTOR ; DIFFERENTIAL ACTIVATION ; CHEMOTACTIC AGONIST ; LIGAND-BINDING ; IDENTIFICATION ; CDNA ; 7-TRANSMEMBRANE ; DOMAINS
资助项目NIAID NIH HHS[AI033503]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000248160700014
出版者PERGAMON-ELSEVIER SCIENCE LTD
源URL[http://119.78.100.183/handle/2S10ELR8/273200]  
专题药物化学研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
国家新药筛选中心
通讯作者Shen, Jing Kang
作者单位1.Univ Illinois, Dept Pharmacol, Chicago, IL USA
2.Natl Ctr Drug Screening, Shanghai, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Wan, Hui-Xin,Zhou, Caihong,Zhang, Yueyun,et al. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1[J]. BIOCHEMICAL PHARMACOLOGY,2007,74(2):317-326.
APA Wan, Hui-Xin.,Zhou, Caihong.,Zhang, Yueyun.,Sun, Meiling.,Wang, Xin.,...&Wang, Ming-Wei.(2007).Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.BIOCHEMICAL PHARMACOLOGY,74(2),317-326.
MLA Wan, Hui-Xin,et al."Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1".BIOCHEMICAL PHARMACOLOGY 74.2(2007):317-326.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。